Twist Bioscience Corp vs Utilities Select Sector SPDR Fund — how do they compare? Twist Bioscience Corp trades at $152.84 (market cap $10.08B), while Utilities Select Sector SPDR Fund trades at $41.09 (market cap $23.60B). The key difference: Utilities Select Sector SPDR Fund is far larger — about 2.3× Twist Bioscience Corp's market cap, and Twist Bioscience Corp is trading nearer its 52-week high, Utilities Select Sector SPDR Fund nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Twist Bioscience Corp for 27 Days and Utilities Select Sector SPDR Fund for 80 Days on average.
| TWST | XLU | |
|---|---|---|
Market Cap | $10.08B | $23.60B |
Volume | 4,229,037 | 28,758,237 |
Sector | Health | — |
52-Week High | $205.00 | $47.73 |
52-Week Low | $25.45 | $39.25 |
Typical Hold Time | 27 Days | 80 Days |
Enterprise Value | $10.01B | — |
Signals from Pluang's Aura AI — not financial advice
TWST trades at $155.65, down 6.78% today, reflecting a bearish technical signal and recent earnings misses. Revenue growth is strong, rising to $376.57M in 2025, but profitability remains elusive with a net income margin of -31.66%. The company's partnership with Lilly TuneLab for AI-driven drug discovery has generated positive news flow, yet cash flow remains negative, and the stock trades at elevated valuation multiples like P/S of 22.01.
The outlook is mixed: strong analyst buy-side consensus (73% Buy) and strategic AI partnerships offer growth potential, but persistent losses, high cash burn, and bearish technicals pose significant risks. Investors face a trade-off between long-term innovation prospects and near-term financial instability.
XLU trades at $41.15, down slightly by 0.02% with mixed technical signals showing a bullish moving average trend but neutral oscillators. The ETF recently hit 52-week lows amid sector-wide pressure from rising interest rates. Recent news highlights utility stocks as oversold with potential defensive appeal during market volatility.
The outlook remains cautious due to interest rate sensitivity, though oversold conditions may present opportunity for defensive positioning. Key risks include continued rate hikes and regulatory pressures, while potential upside exists if utilities regain favor as AI power demand grows.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: electric utilities; water utilities; multi-utilities; independent power and renewable electricity producers; and gas utilities. The fund is non-diversified.
Read more on XLU →